Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Future Medicinal Chemistry
|
February 17, 2015
Structural diversity and potency range distribution of scaffolds from compounds active against current pharmaceutical targets
Shilva Kayastha, Dilyana Dimova, Dagmar Stumpfe, et al.
Expert Opinion on Drug Discovery
|
February 27, 2015
Activity cliff clusters as a source of structure-activity relationship information
Dilyana Dimova, Dagmar Stumpfe, Ye Hu, et al.
Journal of Medicinal Chemistry
|
October 25, 2013
Molecular similarity in medicinal chemistry
Gerald Maggiora, Martin Vogt, Dagmar Stumpfe, et al.
Journal of Chemical Information and Modeling
|
April 16, 2013
Compound pathway model to capture SAR progression: comparison of activity cliff-dependent and -independent pathways
Dagmar Stumpfe, Dilyana Dimova, Kathrin Heikamp, et al.
Molecular Pharmaceutics
|
November 5, 2020
Systematic Data Analysis and Diagnostic Machine Learning Reveal Differences between Compounds with Single- and Multitarget Activity
Christian Feldmann, Dimitar Yonchev, Dagmar Stumpfe, et al.
Journal of Computer-Aided Molecular Design
|
March 7, 2016
Lessons learned from the design of chemical space networks and opportunities for new applications
Martin Vogt, Dagmar Stumpfe, Gerald M Maggiora, et al.
Journal of Chemical Information and Modeling
|
April 12, 2012
MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs
Xiaoying Hu, Ye Hu, Martin Vogt, et al.
Journal of Chemical Information and Modeling
|
September 30, 2011
Development of a method to consistently quantify the structural distance between scaffolds and to assess scaffold hopping potential
Ruifang Li, Dagmar Stumpfe, Martin Vogt, et al.
Journal of Medicinal Chemistry
|
November 5, 2016
Highly Promiscuous Small Molecules from Biological Screening Assays Include Many Pan-Assay Interference Compounds but Also Candidates for Polypharmacology
Erik Gilberg, Swarit Jasial, Dagmar Stumpfe, et al.
Drug Discovery Today
|
March 22, 2018
Redundancy in two major compound databases
Dimitar Yonchev, Dilyana Dimova, Dagmar Stumpfe, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Future Medicinal Chemistry
|
February 17, 2015
Structural diversity and potency range distribution of scaffolds from compounds active against current pharmaceutical targets
Shilva Kayastha, Dilyana Dimova, Dagmar Stumpfe, et al.
Expert Opinion on Drug Discovery
|
February 27, 2015
Activity cliff clusters as a source of structure-activity relationship information
Dilyana Dimova, Dagmar Stumpfe, Ye Hu, et al.
Journal of Medicinal Chemistry
|
October 25, 2013
Molecular similarity in medicinal chemistry
Gerald Maggiora, Martin Vogt, Dagmar Stumpfe, et al.
Journal of Chemical Information and Modeling
|
April 16, 2013
Compound pathway model to capture SAR progression: comparison of activity cliff-dependent and -independent pathways
Dagmar Stumpfe, Dilyana Dimova, Kathrin Heikamp, et al.
Molecular Pharmaceutics
|
November 5, 2020
Systematic Data Analysis and Diagnostic Machine Learning Reveal Differences between Compounds with Single- and Multitarget Activity
Christian Feldmann, Dimitar Yonchev, Dagmar Stumpfe, et al.
Journal of Computer-Aided Molecular Design
|
March 7, 2016
Lessons learned from the design of chemical space networks and opportunities for new applications
Martin Vogt, Dagmar Stumpfe, Gerald M Maggiora, et al.
Journal of Chemical Information and Modeling
|
April 12, 2012
MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs
Xiaoying Hu, Ye Hu, Martin Vogt, et al.
Journal of Chemical Information and Modeling
|
September 30, 2011
Development of a method to consistently quantify the structural distance between scaffolds and to assess scaffold hopping potential
Ruifang Li, Dagmar Stumpfe, Martin Vogt, et al.
Journal of Medicinal Chemistry
|
November 5, 2016
Highly Promiscuous Small Molecules from Biological Screening Assays Include Many Pan-Assay Interference Compounds but Also Candidates for Polypharmacology
Erik Gilberg, Swarit Jasial, Dagmar Stumpfe, et al.
Drug Discovery Today
|
March 22, 2018
Redundancy in two major compound databases
Dimitar Yonchev, Dilyana Dimova, Dagmar Stumpfe, et al.
Page
of 7